Moderna IncMRNA
Price$188.94

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.2B-31.1% YoYTTM through 30 Jun 2026
Net Income -$3.2BTTM through 30 Jun 2026
Free Cash Flow -$1.2BTTM through 30 Jun 2026

Margins

Current
Gross Margin-145.5%
EBITDA Margin-138.7%
Operating Margin-356.8%
Net Margin-141.4%

Returns

-43.1%ROE
-27.8%ROA

Balance Sheet Health

Debt / Equity0.08x
Current Ratio2.41x
Net Debt-$4.6Bnet cash position
Cash & Equivalents$1.7B

Quality Metrics

Altman Z-Score10.63
Piotroski F-Score2 / 9
FCF Margin-55.8%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'21'22'23'24'25
FY2025: $1.9B
Diluted EPS-$7.98TTM
'19'20'21'22'23'24'25
FY2025: $-7.25

Dividend

No dividend

Capital Allocation

Capex Intensity7.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.